The IQWiG methods will be updated again
The IQWiG has just published draft version 6.1 of its “General methods”. The General Methods describe the work procedures of the IQWiG,
Category: News and updates
The G-BA starts the development of a new DMP for obesity
This new DMP for obesity should consider and combine various therapeutic approaches to offer the best possible care, treat patients with obesity
Reimbursement in Germany in real practice
We do often talk about pharmaceutical companies aiming to achieve “reimbursement” for the products, but what does that actually mean in real
NUB method assessments to become faster
Early benefit assessments are completed within 12 months, while method assessments used to take around 3 years. In 2020, the G-BA introduced
The early benefit assessment – 7 new laws since AMNOG
Since 2011, 7 new laws were added to AMNOG to dictate the early benefit assessment of drugs. Therefore, it is often called